Course: Pathway Eased for Serial COVID-19 Screening Tests
CME Credits: 1.00
Released: 2021-04-20
The FDA has created an for manufacturers seeking to obtain Emergency Use Authorization for products used in serial testing to detect SARS-CoV-2 in asymptomatic individuals. Currently, most tests are authorized for diagnosing people with a suspected infection.
Serial testing involves testing the same person more than once over a few days to increase the chances of detecting asymptomatic infection that a single test might not detect. The simplified recommendations apply to molecular and antigen tests used serially in any location, from point-of-care settings to homes, schools, airports, or sports venues.
Educational Objective
To identify the key insights or developments described in this article
View Full Course